Table 4.
False-positive report probability values for the association between CYP1A1 rs4646903 and rs1048943 with cervical cancer risk.
| Model | Crude analysis |
Statistical Power | Prior probability |
|||||
|---|---|---|---|---|---|---|---|---|
| OR (95% Cl) | p-value | 0.25 | 0.1 | 0.01 | 0.001 | 0.0001 | ||
| rs4646903 | ||||||||
| TC vs. TT | 2.41 (1.55–3.76) | 0.0001 | 0.206 | 0.002 | 0.005 | 0.049 | 0.340 | 0.838 |
| CC vs. TT | 4.75 (1.81–12.45) | 0.002 | 0.039 | 0.105 | 0.259 | 0.794 | 0.975 | 0.997 |
| TC + CC vs. TT | 2.67 (1.75–4.07) | <0.0001 | 0.090 | 0.000 | 0.000 | 0.005 | 0.053 | 0.357 |
| CC vs. TT + TC | 3.61 (1.39–9.35) | 0.008 | 0.112 | 0.180 | 0.397 | 0.879 | 0.987 | 0.999 |
| TC vs. TT + CC | 2.13 (1.38–3.30) | 0.0007 | 0.389 | 0.005 | 0.016 | 0.153 | 0.646 | 0.948 |
| Allele | 2.44 (1.71–3.48) | <0.0001 | 0.136 | 0.000 | 0.000 | 0.001 | 0.006 | 0.059 |
| rs1048943 | ||||||||
| AG vs. AA | 1.26 (0.77–2.06) | 0.356 | 0.967 | 0.525 | 0.769 | 0.973 | 0.997 | 1.000 |
| GG vs. AA | 1.47 (0.48–4.48) | 0.497 | 0.706 | 0.679 | 0.864 | 0.986 | 0.999 | 1.000 |
| AG + GG vs. AA | 1.29 (0.81–2.05) | 0.285 | 0.968 | 0.466 | 0.723 | 0.966 | 0.997 | 1.000 |
| (GG vs. AA + AG) | 1.40 (0.46–4.25) | 0.550 | 0.736 | 0.693 | 0.871 | 0.987 | 0.999 | 1.000 |
| (AG vs AA + GG) | 0.83 (0.50–1.37) | 0.459 | 0.976 | 0.589 | 0.811 | 0.979 | 0.998 | 1.000 |
| Allele | 1.28 (0.85–1.92) | 0.244 | 0.985 | 0.415 | 0.680 | 0.959 | 0.996 | 1.000 |
| Haplotypes | ||||||||
| AC | 4.86 (2.65–8.94) | 9.47 × 10−8 | 0.002 | 0.000 | 0.001 | 0.012 | 0.109 | 0.550 |
| AT | 0.45 (0.32–0.63) | 6.72 × 10−6 | 0.270 | 0.000 | 0.000 | 0.001 | 0.012 | 0.109 |
| GC | 1.4 (0.92–2.14) | 0.117 | 0.950 | 0.275 | 0.532 | 0.926 | 0.992 | 0.999 |